US Stock MarketDetailed Quotes
PRTG Portage Biotech
- 0.240
- +0.003+1.35%
Close Apr 26 16:00 ET
- 0.240
- 0.000-0.08%
Post 16:27 ET
4.75MMarket Cap-28P/E (TTM)
0.264High0.230Low63.30KVolume0.242Open0.237Pre Close15.57KTurnover0.62%Turnover RatioLossP/E (Static)19.78MShares4.40052wk High0.15P/B2.45MFloat Cap0.20052wk Low--Dividend TTM10.21MShs Float44.976Historical High--Div YieldTTM14.43%Amplitude0.200Historical Low0.246Avg Price1Lot Size
About Portage Biotech Company
Portage Biotech, Inc. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.
Company Profile
SymbolPRTG
Company NamePortage Biotech
Listing DateFeb 25, 2021
Founded1973
CEODr. Ian B. Walters, M.D.
MarketNASDAQ
Employees7
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
AddressClarence Thomas Building
CityRoad Town
ProvinceTortola
CountryVirgin Islands (British)
Zip CodeVG1110
Phone1-203-221-7378
Company Executives
- Name
- Position
- Salary
- Dr. Ian B. Walters, M.D.
- Chief Executive Officer and Chairman of the Board
- 1.72M
- Allan Lee Shaw
- Chief Financial Officer
- 873.39K
- Brian Wiley
- Chief Business Officer
- 339.03K
- Robert Kramer
- Chief Scientific Officer
- 447.61K
- Justin Fairchild
- Vice President of Development
- 790.46K
- Steven Innaimo
- Vice President of Project Management and Operations
- 520.69K
- Dr. Robert Glassman, M.D.
- Director
- 198.74K
- Steven M. Mintz
- Independent Director
- 96.48K
- Dr. Gregory Hugh Bailey
- Lead Independent Director
- 103.98K
- Mark Simon
- Independent Director
- 90.98K
- James Mellon
- Independent Director
- 86.98K
- Linda Kozick
- Independent Director
- 91.48K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg